Form Type: 4

SEC EDGAR Link
Accession Number:0000947871-21-000788
Date:2021-07-19
Issuer: ACUTUS MEDICAL, INC. (AFIB)
Original Submission Date:

Reporting Person:

ORBIMED ADVISORS LLC
601 LEXINGTON AVENUE
54TH FLOOR NEW YORK, NY 10022-4629

Reporting Person:

ORBIMED CAPITAL GP IV LLC
601 LEXINGTON AVENUE, 54TH FLOOR
NEW YORK, NY 10022

Reporting Person:

ORBIMED ROF II LLC
601 LEXINGTON AVE., 54TH FLOOR
NEW YORK, NY 10022

Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
Title of SecurityTransaction Date2a. Deemed Execution Date Transaction CodeSharesAcquired or DisposedPrice per share 5. Amount of Securities Beneficially Owned Following Reported Transaction 6. Ownership Form Direct or IndirectNature of Indirect Ownership
COMMON STOCK 2021-07-19 P 714,285 a $14.00 4,872,025 indirect f2,f4
COMMON STOCK 2021-07-19 P 357,143 a $14.00 1,677,361 indirect f3,f4
COMMON STOCK 2021-07-19 0 $0.00 4,022 indirect f5
Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, convertible securities
Title of Derivative Security Conversion or Exercise Price of Derivative Security Transaction Date Deemed Execution Date Transaction Code Number of Derivative Securities Acquired (A) or Disposed of (D) Date ExercisableExpiration Date Title and Amount of Securities Underlying Derivative Security Price of Derivative Security Number of derivative Securities Beneficially Owned Following Reported Transaction(s) Ownership Form: Direct (D) or Indirect (I) Nature of Indirect Beneficial Ownership
Footnotes
IDfootnote
f1 these shares of the issuer's common stock were purchased in the issuer's underwritten public offering.
f2 these shares of the issuer's common stock are held of record by orbimed private investments iv, lp ("opi iv"). orbimed capital gp iv llc ("gp iv") is the general partner of opi iv, and orbimed advisors llc ("orbimed advisors"), a registered investment adviser under the investment advisors act of 1940, as amended, is the managing member of gp iv. orbimed advisors and gp iv exercise investment and voting power through a management committee comprised of carl l. gordon, sven h. borho, and w. carter neild, each of whom disclaims beneficial ownership of the shares held by opi iv.
f3 these shares of the issuer's common stock are held of record by orbimed royalty opportunities ii, lp ("oro ii"). orbimed rof ii llc ("rof ii") is the general partner of oro ii, and orbimed advisors is the managing member of oro ii. orbimed advisors and rof ii exercise investment and voting power through a management committee comprised of carl l. gordon, sven h. borho, and w. carter neild, each of whom disclaims beneficial ownership of the shares held by oro ii.
f4 this report on form 4 is jointly filed by gp iv, rof ii, and orbimed advisors. each of the reporting persons disclaims beneficial ownership of the securities reported herein for purposes of rule 16a-1(a) under the securities exchange act of 1934, as amended (the "exchange act"), except to the extent of its pecuniary interest therein, if any. orbimed advisors and gp iv have designated david bonita ("bonita"), a member of orbimed advisors, to serve on the issuer's board of directors. this report shall not be deemed an admission that any of the reporting persons, or bonita, is a beneficial owner of such securities for the purposes of section 16 of the exchange act, or for any other purposes.
f5 represents shares of the issuer's common stock received by bonita for service on the issuer's board of directors. pursuant to an agreement with orbimed advisors and gp iv, bonita is obligated to transfer these securities, or the economic benefit thereof, to orbimed advisors and gp iv, which will in turn ensure that such securities or economic benefits are provided to opi iv.
WhaleWisdom Logo

Elevate your investments